Carmen Hartmayer
Overview
Explore the profile of Carmen Hartmayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bloes D, Haasbach E, Hartmayer C, Hertlein T, Klingel K, Kretschmer D, et al.
Infect Immun
. 2017 Sep;
85(12).
PMID: 28893917
Influenza A virus (IAV) infection is often followed by secondary bacterial lung infection, which is a major reason for severe, often fatal pneumonia. Community-associated methicillin-resistant (CA-MRSA) strains such as USA300...
2.
Herrmann V, Hartmayer C, Planz O, Groettrup M
J Control Release
. 2015 Aug;
216:121-31.
PMID: 26276509
Current influenza virus vaccines aim to elicit antibodies directed toward viral surface glycoproteins, which however are prone to antigenic drift. Cytotoxic T lymphocytes (CTLs) can exhibit heterosubtypic immunity against most...
3.
Haasbach E, Hartmayer C, Hettler A, Sarnecka A, Wulle U, Ehrhardt C, et al.
Front Microbiol
. 2014 May;
5:171.
PMID: 24795704
Influenza, a respiratory disease caused by influenza viruses, still represents a major threat to humans and several animal species. Besides vaccination, only two classes of drugs are available for antiviral...
4.
Haasbach E, Hartmayer C, Planz O
Antiviral Res
. 2013 Mar;
98(2):319-24.
PMID: 23523553
MEK inhibitors are very potent and promising compounds in cancer therapy. Earlier investigations have demonstrated that they also possess antiviral properties against influenza virus. This is due to the fact...